Diagnostic value of hemostasis activation markers in acute deep vein thrombosis;Diagnostyczne znaczenie oznaczania markerów aktywacji hemostazy w ostrej zakrzepicy żył głçbokich

Polskie Archiwum Medycyny Wewnetrznej

Volumn 107, Issue 3, 2002, Pages 237-241

  Tajanko, Elzbieta ^b   Galar, Marzenna ^b   Piszcz, Jarosław ^b   Kłoczko, Janusz ^a  

^a Klinika Hematologii   (Poland)

^b NONE

Author keywords

D dimer; Deep venous thrombosis (DVT); Plasmin 2 antiplasmin complex (PAP); Thrombin antithrombin complex (TAT)

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTIPLASMIN; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PLASMIN; PLASMIN PLASMIN INHIBITOR COMPLEX; PLASMIN-PLASMIN INHIBITOR COMPLEX; PROTHROMBIN; PROTHROMBIN FRAGMENT 1.2;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HEMOSTASIS; HUMAN; MALE; METABOLISM; NONPARAMETRIC TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VEIN THROMBOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; LOGISTIC MODELS; MALE; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLASMIN; PROTHROMBIN; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; VENOUS THROMBOSIS;

EID: 0036491918     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Agnelli G., Radicchia S., Nenci G.: Diagnosis of deep vein thrombosis in asymptomatic high-risk patients. Haemost., 1995, 25, 40.
2. Harris W.H., Athanasoulis C., Waltman A.C., Salzman E.W.: Cuff- impedance phlebography and I-fibrinogen scanning versus roentgenographic phlebography for diagnosis of thrombophlebitis following hip surgery. J. Bone Joint. Surg., 1976, 58, 934.
3. Glowiński S., Kłoczko J.: Zarys hemostazy i trombogenezy. [w:] Noszczyk W.: Chirurgia tȩtnic i żyobwodowych. Wydawnictwo Lekarsie PZWL, Warszawa 1998, 53.
4. Zawilska K.: Markery wewna̧trznaczyniowej aktywacji krzepniȩcia. Acta Haematol. Pol., 1995, 25, (suppl. 2), 27.
5. Zawilska K.: Postȩpy w diagnostyce wewna̧trznaczyniowej aktywacji fibrynolizy. Acta Haematol. Pol., 1995, 26.
6. Jastrzȩbska M.: Znaczenie D-dimerów w diagnostyce zaburzeń hemostazy. Warszawa, 1998, Bio-Merieux Polska.
7. Laaban J.P., Achkar A., Horrelou M.H. i wsp.: Value of plasma D-dimer assays in the diagnosis of venous thromboembolism. Rev. Mal. Respin, 1997, 14, 119.
8. van Beek E.J., Schenk B.E., Michel B.C. i wsp.: The role of plasma D-dimer concentration in the exclusion of pulmonary embolism. Br. J. Haematol., 1996, 92, 492.
9. LaCapra S., Arkel Y.S., Ku D.H., Gibson D., Lake C., Lam X: The use of thrombus precursor protein, D-dimer, prothrombin fragment 1+2, and thrombin-antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism. Blood Coagul. and Fibrynol., 2000, 11, 371.
10. Legnani C., Pancani C., Palareti C. i wsp.: Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients. Blood Coagul. Fibrynol., 1997, 8, 296.
11. Speiser W., Mallek R., Koppensteiner R. i wsp.: D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb. Haemost., 1990, 64, 196.
12. Confrancesco E., Cortellaro M., Corradi A., Ravasi F., Bertocchi F.: Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery. Thromb. Haemost., 1997, 77, 267.
13. Confrancesco E., Cortellaro M., Corradi A., Ravasi R, Bertocchi E: Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurement in the diagnosis of deep vein thrombosis following total hip replacement. Thromb. Haemost., 1998, 79, 509.
14. Boneu B., Bes G., Pelzer H., Sie P., Boccalon H: D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb. Haemost., 1991, 65, 28.
15. Kyrle P.A., Eichinger S., Pabinger I. i wsp.: Prothrombin fragment 1+2 is not predictive for reccurent venous thromboembolism. Thromb. Haemost., 1997, 77, 829.